Biggest News Aggregation in the World
📰 Henan News

Page 37 - Henan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Henan. Real-time updates on events, politics, business and more.

GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting

SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in
United States Yu Wang Vanesa Gregorc Rafael Rosell China National Medical Products Administration American Society Of Clinical Oncology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science